QOP
MED icon

Quinn Opportunity Partners’s Medifast MED Stock Holding History

Quinn Opportunity Partners’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Hold
127,112
– – 0.06% 203
2026
Q1 		$1.3M Hold
127,112
– – 0.07% 194
2025
Q4 		$1.36M Hold
127,112
– – 0.06% 202
2025
Q3 		$1.74M Hold
127,112
– – 0.12% 151
2025
Q2 		$1.79M Buy
127,112
+4,940
+4% +$64.9K 0.15% 142
2025
Q1 		$1.65M Buy
122,172
+50,565
+71% +$759K 0.11% 178
2024
Q4 		$1.26M Sell
71,607
-45,378
-39% -$842K 0.09% 182
2024
Q3 		$2.24M Buy
+116,985
New +$2.25M 0.22% 99

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Quinn Opportunity Partners's MED Position: Q2 2026 in Review

Quinn Opportunity Partners held its Medifast (MED) position steady in Q2 2026 at 127,112 shares worth $1.35M. The position accounts for 0.06% of the portfolio, ranked #203.

Quinn Opportunity Partners first reported a position in MED in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.24M in Q3 2024. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • Quinn Opportunity Partners held 127,112 shares of Medifast worth $1.35M as of Q2 2026.
  • Quinn Opportunity Partners left its Medifast share count unchanged in Q2 2026.
  • Medifast made up 0.06% of Quinn Opportunity Partners's portfolio in Q2 2026, its #203 holding.
  • Quinn Opportunity Partners first reported a position in Medifast in Q3 2024 and has held it in 8 quarters since.
  • Quinn Opportunity Partners's Medifast position peaked at $2.24M in Q3 2024.
  • 113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Quinn Opportunity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.